Evidence map›Paper›PMID 22274555›Full record

ArticlePharmaceutical research2012

Formulation and in vitro characterization of composite biodegradable magnetic nanoparticles for magnetically guided cell delivery.

Michael Chorny, Ivan S Alferiev, Ilia Fishbein, Jillian E Tengood, Zoë Folchman-Wagner, Scott P Forbes, Robert J Levy

Open access · greenAbstract read
In one paragraph

Article in Pharmaceutical research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Article
  10. Real-time analysis of composite magnetic nanoparticle disassembly in vascular cells and biomimetic media.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michael ChornyDivision of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. chorny@email.chop.edu
Ivan S Alferiev
Ilia Fishbein
Jillian E Tengood
Zoë Folchman-Wagner
Scott P Forbes
Robert J Levy
Children's Hospital of Philadelphia · US

Funding

Training in Molecular Therapeutics for Pediatric CardiologyT32HL007915 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Robert J Levy, JOSEPH W ROSSANO · 1999 to 2026
$13.4M
Gene Delivery StentsR01HL072108 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI LEVY, ROBERT J · 2003 to 2013
$3.9M
High Field Gradient Targeting Magnetic Nanoparticle Loaded Cells to StentsR21HL094816 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI LEVY, ROBERT J · 2011 to 2012
$457k
Gene Delivery Stents AAV FormulationsR56HL072108 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI FISHBEIN, ILIA, LEVY, ROBERT J · 2015 to 2015
$420k
NHLBI NIH HHS HL72108NHLBI NIH HHS HL94816NHLBI NIH HHS R01 HL072108NHLBI NIH HHS R21 HL094816NHLBI NIH HHS R56 HL072108NHLBI NIH HHS T32 HL007915
6 · The paper itself

Abstract

purposeCells modified with magnetically responsive nanoparticles (MNP) can provide the basis for novel targeted therapeutic strategies. However, improvements are required in the MNP design and cell treatment protocols to provide adequate magnetic properties in balance with acceptable cell viability and function. This study focused on select variables controlling the uptake and cell compatibility of biodegradable polymer-based MNP in cultured endothelial cells.

methodsFluorescent-labeled MNP were formed using magnetite and polylactide as structural components. Their magnetically driven sedimentation and uptake were studied fluorimetrically relative to cell viability in comparison to non-magnetic control conditions. The utility of surface-activated MNP forming affinity complexes with replication-deficient adenovirus (Ad) for transduction achieved concomitantly with magnetic cell loading was examined using the green fluorescent protein reporter.

resultsA high-gradient magnetic field was essential for sedimentation and cell binding of albumin-stabilized MNP, the latter being rate-limiting in the MNP loading process. Cell loading up to 160 pg iron oxide per cell was achievable with cell viability >90%. Magnetically driven uptake of MNP-Ad complexes can provide high levels of transgene expression potentially useful for a combined cell/gene therapy.

conclusionsMagnetically responsive endothelial cells for targeted delivery applications can be obtained rapidly and efficiently using composite biodegradable MNP.

Indexed as

Drug Delivery SystemsMagneticsNanoparticlesAbsorbable ImplantsAnimalsCattleCells, CulturedCell SurvivalChemistry, PharmaceuticalDrug StabilityEndothelial CellsFerrosoferric OxideFluorescent DyesGene Transfer TechniquesKineticsMolecular StructureFerrosoferric OxideFluorescent DyesPolyesterspoly(lactide)Surface-Active Agents

Identifiers

PMID22274555
PMCPMC3336034
OpenAlexW2070424864

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.